(Q48290740)

English

Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.

scientific article published on 28 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

0 references

0 references

José Luis Molinuevo

4

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

8

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

11

object named as

Eduardo Tolosa

1 reference

Europe PubMed Central

10 February 2018

Francesc Valldeoriola

2

object named as

Francesc Valldeoriola

1 reference

Europe PubMed Central

10 February 2018

author name string

Alex Iranzo

1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

Francisco Lomeña

3

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

Mónica Serradell

5

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

Manel Salamero

6

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

Albert Cot

7

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

Javier Pavía

9

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

Joan Santamaria

10

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

publication date

28 July 2011

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

Lancet Neurology

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

10

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

9

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

797-805

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

"Disease-modification" trials in Parkinson disease: target populations, endpoints and study design

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining disease-modifying therapies for PD--a road map for moving forward

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and the premotor phase of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rate of cell death in parkinsonism indicates active neuropathological process

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased striatal dopaminergic innervation in REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-specific progression of nigrostriatal dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Follow-up PET studies in case of idiopathic REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Excessive muscle activity increases over time in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in network activity with the progression of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and [18F] dopa PET findings in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamen.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970152-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(11)70152-1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/21802993

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48290740&oldid=1417974257"